Program of Tropical and Infectious Diseases, Aklilu Lemma Institute of Pathobiology, 37602Addis Ababa University, Addis Ababa, Ethiopia; and staff and researcher at the 128164Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Program of Tropical and Infectious Diseases, Aklilu Lemma Institute of Pathobiology, 37602Addis Ababa University, Addis Ababa, Ethiopia.
Cancer Control. 2022 Jan-Dec;29:10732748221114980. doi: 10.1177/10732748221114980.
The aim of this study was to evaluate the performance of visual inspection with acetic acid compared with Human papillomavirus Deoxyribonucleic acid (HPV DNA) testing among women with HIV in Ethiopia.
A comparative cross-sectional study was conducted to address the aforementioned objective. Data were collected from January to October 2021, to compare the performance of these two screening modalities. Trained clinicians collected cervical specimens and immediately applied acetic acid for visual inspection. The HPV DNA testing was done using Abbott m2000rt/SP by trained laboratory professionals in accredited laboratories. A total of 578 women with HIV aged 25-49 years were included.
Test positivity was 8.9% using visual inspection with acetic acid (VIA) and 23.3% using HPV DNA test. The sensitivity and specificity of the VIA test were 19.2% and 95.1%, respectively. The strength of agreement between the two screening methods was poor (k = .184). The burden of genetic distribution of high risk HPV16 was 6.1%, and HPV18 was 1.1%. Other high risk HPV types (ie non-HPV 16/18 high risk HPV genotypes) were predominant in this study (18.6%).
The higher positivity result using HPV DNA testing compared with VIA, and low sensitivity of VIA are indicating that the implementation of HPV DNA testing as the primary screening strategy is likely to reduce cervical cancer cases and deaths of women in the country.
本研究旨在评估醋酸视觉检查在埃塞俄比亚 HIV 女性中的表现,并与人类乳头瘤病毒脱氧核糖核酸(HPV DNA)检测进行比较。
进行了一项横断面比较研究,以解决上述目标。数据收集于 2021 年 1 月至 10 月,以比较这两种筛查方式的性能。经过培训的临床医生收集宫颈标本,并立即应用醋酸进行视觉检查。HPV DNA 检测使用雅培 m2000rt/SP 由经过培训的实验室专业人员在认可的实验室进行。共纳入 578 名年龄在 25-49 岁的 HIV 阳性女性。
醋酸视觉检查(VIA)的检测阳性率为 8.9%,HPV DNA 检测为 23.3%。VIA 检测的敏感性和特异性分别为 19.2%和 95.1%。两种筛查方法之间的一致性较弱(k =.184)。高危 HPV16 的遗传分布负担为 6.1%,HPV18 为 1.1%。在本研究中,其他高危 HPV 类型(即非 HPV16/18 高危 HPV 基因型)更为常见(18.6%)。
与 VIA 相比,HPV DNA 检测的阳性率更高,而 VIA 的敏感性较低,这表明实施 HPV DNA 检测作为主要筛查策略可能会减少该国女性的宫颈癌病例和死亡人数。